alloxan has been researched along with benzo(a)pyrene in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bathina, S; Das, UN; Srinivas, N | 1 |
Bathina, S; Das, UN | 1 |
2 other study(ies) available for alloxan and benzo(a)pyrene
Article | Year |
---|---|
BDNF protects pancreatic β cells (RIN5F) against cytotoxic action of alloxan, streptozotocin, doxorubicin and benzo(a)pyrene in vitro.
Topics: Alloxan; Animals; Apoptosis; Benzo(a)pyrene; Brain-Derived Neurotrophic Factor; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Resistance; Gene Expression Regulation; Humans; Insulin; Insulin Secretion; Insulin-Secreting Cells; Kinetics; Models, Biological; Poisons; Rats; Recombinant Proteins; Streptozocin | 2016 |
PUFAs, BDNF and lipoxin A4 inhibit chemical-induced cytotoxicity of RIN5F cells in vitro and streptozotocin-induced type 2 diabetes mellitus in vivo.
Topics: Alloxan; Animals; Arachidonic Acid; Benzo(a)pyrene; Brain-Derived Neurotrophic Factor; Cell Death; Cell Line, Tumor; Cytotoxins; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Doxorubicin; Drug Interactions; Fatty Acids, Unsaturated; Insulin-Secreting Cells; Insulinoma; Lipoxins; Pancreatic Neoplasms; Rats; Rats, Wistar; Streptozocin | 2019 |